Treatment of Vulvar Intraepithelial Neoplasia — HSIL (Usual-Type VIN), HPV-Related, with Occult Invasion Ruled Out
Clinical Scenario
This protocol addresses HSIL (usual-type VIN), the HPV-related form of vulvar intraepithelial neoplasia, in a patient who is not pregnant and not immunosuppressed, and in whom occult invasion has been definitively excluded.
Specific Situation
Ruling out occult invasion is the key prerequisite in this scenario. Ablative or topical therapies are appropriate for HSIL (usual-type VIN) only after invasion has been excluded — this confirmation determines which management approaches can be offered.
Approach — Partial Overview
Excision is the treatment of choice, though once invasion is excluded, anatomy-preserving alternatives — including ablative or topical strategies, alone or in combination with excision — may also be considered. Which option applies depends on lesion characteristics detailed in the full protocol.
References
- The treatment of choice for differentiated-type VIN is excision. Ablative or topical therapies may be used in HSIL (usual-type VIN) after ruling out occult invasion.
- Topical therapy alone or in combination with destructive or excisional therapies is indicated in the treatment of HSIL (usual-type VIN) in unifocal or multifocal isolated lesions after having ruled out occult invasion.
- Excision is the treatment of choice for differential VIN and HSIL (usual-type VIN) with no secondary lesions from ablation or topical treatments.
- Ablation and/or combined therapies may be used in cases in which invasion is ruled out.
View source ↗